Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48	49	49	42	36	35
Market Cap Growth	0.69%	0.69%	15.82%	16.13%	2.15%	-1.04%
Enterprise Value	41	43	41	39	37	39
Last Close Price	2.66	2.72	2.63	2.19	1.81	1.72
PE Ratio	13.40	13.68	9.83	8.23	7.72	13.39
PS Ratio	1.69	1.73	1.73	1.28	1.10	1.37
PB Ratio	0.94	0.96	0.99	0.91	0.74	0.81
P/TBV Ratio	0.98	1.00	1.03	0.94	0.80	0.89
P/FCF Ratio	6.78	6.94	8.72	3.62	13.20	111.66
P/OCF Ratio	5.74	5.87	7.44	3.47	8.42	26.14
EV/Sales Ratio	1.46	1.52	1.47	1.18	1.12	1.50
EV/EBITDA Ratio	7.01	7.64	5.73	5.19	5.20	9.16
EV/EBIT Ratio	8.68	9.05	6.49	6.20	6.48	13.58
EV/FCF Ratio	5.85	6.10	7.44	3.35	13.40	122.00
Debt / Equity Ratio	0.02	0.02	0.04	0.03	0.04	0.06
Debt / EBITDA Ratio	0.18	0.18	0.23	0.20	0.25	0.61
Debt / FCF Ratio	0.15	0.15	0.32	0.13	0.68	8.62
Asset Turnover	0.45	0.45	0.47	0.54	0.56	0.49
Inventory Turnover	2.10	2.10	1.72	1.79	1.61	1.40
Quick Ratio	3.34	3.34	2.97	2.88	2.80	2.49
Current Ratio	4.29	4.29	4.11	3.86	4.25	4.18
Return on Equity (ROE)	7.21%	7.21%	10.45%	10.77%	9.55%	6.30%
Return on Assets (ROA)	4.77%	4.77%	6.60%	6.45%	6.06%	3.38%
Return on Capital (ROIC)	5.80%	5.80%	8.09%	7.94%	7.29%	4.03%
Return on Capital Employed (ROCE)	8.70%	8.70%	12.10%	12.60%	10.80%	6.00%
Earnings Yield	747.29%	7.31%	10.17%	12.15%	12.95%	7.47%
FCF Yield	1474.67%	14.42%	11.46%	27.64%	7.58%	0.90%
Dividend Yield	266.66%	-	2.70%	4.87%	4.70%	3.29%
Payout Ratio	3352.38%	33.52%	36.63%	29.90%	20.25%	44.33%
Total Shareholder Return	266.66%	-	2.70%	4.87%	4.70%	3.29%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.